ExploreWatchlistsPricing
  1. JP-listed companies
  2. Japan Tissue Engineering Co., Ltd.
  3. Financials
  4. EBITDA margin (%)

Japan Tissue Engineering Co., Ltd. (7774)

Market cap
¥24.3B
P/E ratio
-45x
Develops and manufactures regenerative medicine products that restore tissue function by culturing patients' own cells for transplantation.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndEBITDA margin (%) YoY (%)
Mar 31, 2025-3.3-129.35%
Mar 31, 202411.1-137.74%
Mar 31, 2023-29.4+65.46%
Mar 31, 2022-17.7+18.29%
Mar 31, 2021-15+212.03%
Mar 31, 2020-4.8-50.73%
Mar 31, 2019-9.8-167.63%
Mar 31, 201814.4-27.58%
Mar 31, 201719.9-148.59%
Mar 31, 2016-41-9.95%
Mar 31, 2015-45.5

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat